LoperamideREGNARD, Claud; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2011, Vol 42, Num 2, pp 319-323, issn 0885-3924, 5 p.Article

Keeping the Cecum Clean: A Randomized, Prospective, Placebo-Controlled Trial of Loperamide as Part of Preparation for ColonoscopyCHURCH, James; BAST, Jane; ELAYI, Elodie et al.Diseases of the colon & rectum. 2013, Vol 56, Num 1, pp 120-125, issn 0012-3706, 6 p.Article

LOPERAMIDE IN THE SYMPTOMATIC CONTROL OF CHRONIC DIARRHOEA. DOUBLE-BLIND PLACEBO-CONTROLLED STUDY = LE LOPERANIDE DANS LE CONTROLE SYMPTOMATIQUE DE LA DIARRHEE CHRONIQUE. ETUDE CONTROLEE EN DOUBLE AVEUGLE AVEC UN PLACEBOTIJTGAT GN; MEUWISSEN SGM; HUIBREGTSE K et al.1975; ANN. CLIN. RES.; FINL.; DA. 1975; VOL. 7; NO 5; PP. 325-330; BIBL. 15 REF.Article

Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochlorideTROTTET, L; MERLY, C; MIRZA, M et al.International journal of pharmaceutics. 2004, Vol 274, Num 1-2, pp 213-219, issn 0378-5173, 7 p.Article

LOPERAMIDE: A NEW ANTIDIARRHEAL AGENT IN THE TREATMENT OF CHRONIC DIARRHEAGALAMBOS JT; HERSH T; SCHRODER S et al.1976; GASTROENTEROLOGY; U.S.A.; DA. 1976; VOL. 70; NO 6; PP. 1026-1029; BIBL. 12 REF.Article

LOPERAMIDE (R 18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. I. IN VIVO ORAL PHARMACOLOGY AND ACUTE TOXICITY COMPARISON WITH MORPHINE, CODEINE, DIPHENOXYLATE AND DIFENOXINE = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. I. PHARMACOLOGIE ET TOXICITE AIGUE PER OS. COMPARAISON AVEC LA MORPHINE, LA CODEINE, LE DIPHENOXYLATE ET LA DIFENOXINENIEMEGEERS CJE; LENAERTS FM; JANSSEN PAJ et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1633-1636; ABS. ALLEM.; BIBL. 6REF.Article

LOPERAMIDE (R 18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. II. IN VIVO PARENTERAL PHARMACOLOGY AND ACUTE TOXICITY IN MICE COMPARISON WITH MORPHINE, CODEINE AND DIPHENOXYLATE = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. II. PHARMACOLOGIE ET TOXICITE AIGUE PAR VOIE PARENTERALE. COMPARAISON AVEC LA MORPHINE, LA CODEINE ET LE DIPHENOXYLATENIEMEGEERS CJE; LENAERTS FM; JANSSEN PAJ et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1636-1641; ABS. ALLEM.; BIBL. 4REF.Article

LOPERAMIDE (R18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. IV.STUDIES ON SUBACUTE AND CHRONIC TOXICITY AND THE EFFECT ON REPRODUCTIVE PROCESSES IN RATS, DOGS AND RABBITS = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. IV. ETUDES DE TOXICITE SUBAIGUE ET CHRONIQUE ET EFFET SUR LES MECANISMES DE REPRODUCTION CHEZ LE RAT, LE CHIEN ET LE LAPINMARSBOOM R; HERIN V; VERSTRAETEN A et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1645-1649; ABS. ALLEM.; BIBL. 3REF.Article

PROBABLE INTERACTION OF LOPERAMIDE AND HOLESTYRAMINETI TY; GILES HG; SELLERS EM et al.1978; CANAD. MED. ASS. J.; CAN; DA. 1978; VOL. 119; NO 6; PP. 607-608; BIBL. 6 REF.Article

LOPERAMIDE ANTAGONISM OF CASTOR OIL-INDUCED DIARRHEA IN RATS: A QUANTITATIVE STUDY. = ANTAGONISME DU LOPERAMIDE CONTRE LA DIARRHEE A L'HUILE DE RICIN CHEZ LE RAT: ETUDE QUANTITATIVEAWOUTERS F; NIEMEGEERS CJE; KUYPS J et al.1975; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1975; VOL. 217; NO 1; PP. 29-37; BIBL. 24 REF.Article

LOPERAMIDE (R18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. VI.CLINICAL PHARMACOLOGY PLACEBO-CONTROLLED COMPARISON OF THE CONSTIPATING ACTIVITY AND SAFETY OF LOPERAMIDE, DIPHENOXYLATE AND CODEINE IN NORMAL VOLUNTEERS = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. VI.PHARMACOLOGIE CLINIQUE: COMPARAISON DE L'ACTION ASTRINGEANTE ET DE L'INNOCUITE DU LOPERAMIDE, DU DIPHENOXYLATE ET DE LA CODEINE CHEZ DES VOLONTAIRES SAINS, AVEC CONTROLE PLACEBOSCHUERMANS V; VAN LOMMEL R; DOM J et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1653-1657; ABS. ALLEM.; BIBL. 15REF.Article

Effect of opioid μ-receptors activation on insulin signals damaged by tumor necrosis factor α in myoblast C₂C₁₂ cellsWEN CHING KO; TSANG PAI LIU; CHENG, Juei-Tang et al.Neuroscience letters. 2006, Vol 397, Num 3, pp 274-278, issn 0304-3940, 5 p.Article

Perte de connaissance chez une jeune enfant secondaire à la prise de lopéramide = Loss of consciousness in a child due to loperamideCHANZY, S; MORETTI, S; MAYET, H et al.Archives de pédiatrie (Paris). 2004, Vol 11, Num 7, pp 826-827, issn 0929-693X, 2 p.Article

Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels and Pain : Ion channels as therapeutic targes for neuropathic painDUNLOP, J; VASILYEV, D; LU, P et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 15, pp 1767-1772, issn 1381-6128, 6 p.Article

LOPERAMIDE (R18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. V.THE PHARMACOKINETICS OF LOPERAMIDE IN RATS AND MAN = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. V.PHARMACOCINETIQUE CHEZ LE RAT ET CHEZ L'HOMMEHEYKANTS J; MICHIELS M; KNAEPS A et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1649-1653; ABS. ALLEM.; BIBL. 10REF.Article

LOPERAMIDE (R18553), A NOVEL TYPE OF ANTIDIARRHEAL AGENT. VII.CLINICAL INVESTIGATION EFFICACITY AND SAFETY OF LOPERAMIDE IN PATIENTS WITH SEVERE CHRONIC DIARRHEA = LE LOPERAMIDE, UN NOUVEAU TYPE D'ANTIDIARRHEIQUE. VII.ETUDE CLINIQUE: EFFICACITE ET INNOCUITE DU LOPERAMIDE CHEZ DES PATIENTS ATTEINTS DE DIARRHEE CHRONIQUE GRAVEVERHAEGEN H; DE CREE J; SCHUERMANS V et al.1974; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1974; VOL. 24; NO 10; PP. 1657-1660; ABS. ALLEM.; BIBL. 14REF.Article

A MULTICENTRE DOUBLE-BLIND STUDY IN ACUTE DIARRHOEA COMPARING LOPERAMIDE (R 18553) WITH TWO COMMON ANTIDIARRHOEAL AGENTS AND A PLACEBOAMERY W; DUYCK F; POLAK J et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 17; NO 3; PP. 263-270; BIBL. 1 P.Article

ABUSE POTENTIAL OF LOPERAMIDEJAFFE JH; KANZLER M; GREEN J et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 6; PP. 812-819; BIBL. 9 REF.Article

Relations entre motricité, transit et absorptin hydrique au niveau du côlon: approche physiologique et pharmacologique = Relationships between colonic motility, transit and net water absorption: a physiological and pharmacological studyTheodorou-Bayle, Vassilia; Fioramonti, Jean.1992, 158 p.Thesis

Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screeningXING WEN GONG; JUN HUA MAI; YU HONG XU et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 7, pp 2388-2392, issn 0960-894X, 5 p.Article

Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrheaKUGE, Tomoo; SHIBATA, Takashi; WILLETT, Michael S et al.Clinical therapeutics. 2004, Vol 26, Num 10, pp 1644-1651, issn 0149-2918, 8 p.Article

Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomesKIM, Kyoung-Ah; CHUNG, Jaegul; JUNG, Dong-Hae et al.European journal of clinical pharmacology. 2004, Vol 60, Num 8, pp 575-581, issn 0031-6970, 7 p.Article

Mediation of protein kinase C zeta in μ-opioid receptor activation for increase of glucose uptake into cultured myoblast C₂C₁₂ cellsYANG, Ting-Ting; LIU, I-Min; WU, Hung-Tsung et al.Neuroscience letters. 2009, Vol 465, Num 2, pp 177-180, issn 0304-3940, 4 p.Article

μ-Opiate receptor agonists - : a new pharmacological approach to prevent motion sickness?OTTO, Bärbel; RIEPL, Rudolf L; OTTO, Carsten et al.British journal of clinical pharmacology. 2006, Vol 61, Num 1, pp 27-30, issn 0306-5251, 4 p.Article

Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male ParticipantsCHA, Yu-Jung; LEE, Howard; CHO, Joo-Youn et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 113, Num 6, pp 419-424, issn 1742-7835, 6 p.Article